CD33 and Alzheimer disease: The inverse variance weighted method was used as the primary estimator.<h4>Results</h4>The analysis revealed that elevated levels of CD33 on CD33dim HLA DR+ CD11b+ and CD33 on CD33dim HLA DR+ CD11b- were associated with an increased risk of AD.